Article Text

Original research article
Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery
  1. David L Prior1,2,3,
  2. Jithendra B Somaratne1,
  3. Alicia J Jenkins2,
  4. Michael Yii4,5,
  5. Andrew E Newcomb4,5,
  6. Casper G Schalkwijk6,
  7. Mary J Black7,
  8. Darren J Kelly2 and
  9. Duncan J Campbell2,3
  1. 1Department of Cardiology, St. Vincent's Hospital Melbourne, Fitzroy, Australia
  2. 2Department of Medicine, University of Melbourne, St. Vincent's Hospital Melbourne, Fitzroy, Australia
  3. 3St. Vincent's Institute of Medical Research, Fitzroy, Australia
  4. 4Department of Cardiothoracic Surgery, St. Vincent's Hospital Melbourne, Fitzroy, Australia
  5. 5Department of Surgery, University of Melbourne, St. Vincent's Hospital Melbourne, Fitzroy, Australia
  6. 6Department of Internal Medicine, University of Maastricht, Maastricht, The Netherlands
  7. 7Department of Anatomy and Developmental Biology, Monash University, Clayton, Australia
  1. Correspondence to Professor David L Prior; David.PRIOR{at}svhm.org.au

Abstract

Objective The reported association between calibrated integrated backscatter (cIB) and myocardial fibrosis is based on study of patients with dilated or hypertrophic cardiomyopathy and extensive (mean 15–34%) fibrosis. Its association with lesser degrees of fibrosis is unknown. We examined the relationship between cIB and myocardial fibrosis in patients with coronary artery disease.

Methods Myocardial histology was examined in left ventricular epicardial biopsies from 40 patients (29 men and 11 women) undergoing coronary artery bypass graft surgery, who had preoperative echocardiography with cIB measurement.

Results Total fibrosis (picrosirius red staining) varied from 0.7% to 4%, and in contrast to previous reports, cIB showed weak inverse associations with total fibrosis (r=−0.32, p=0.047) and interstitial fibrosis (r=−0.34, p=0.03). However, cIB was not significantly associated with other histological parameters, including immunostaining for collagens I and III, the advanced glycation end product (AGE) Nε-(carboxymethyl)lysine (CML) and the receptor for AGEs (RAGE). When biomarkers were examined, cIB was weakly associated with log plasma levels of amino-terminal pro-B-type natriuretic peptide (r=0.34, p=0.03), creatinine (r=0.33, p=0.04) and glomerular filtration rate (r=−0.33, p=0.04), and was more strongly associated with log plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) (r=0.44, p=0.01) and soluble RAGE (r=0.53, p=0.002).

Conclusions Higher cIB was not a marker of increased myocardial fibrosis in patients with coronary artery disease, but was associated with higher plasma levels of sVEGFR-1 and soluble RAGE. The role of cIB as a non-invasive index of fibrosis in clinical studies of patients without extensive fibrosis is, therefore, questionable.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.